|
| |
| | Reverse Transcriptase |
 | | RT sequence alignment used in our analysis of clinical HIV-1 isolates [supplement to Wrobel et al. |  | | Click here to view more interactive Reverse Transcriptase images |  | | View HIV-1 and MMLV Reverse Transcriptase structures (requires Chime plug-in) |
|
http://www.unc.edu/~wrobel/rt.html
(421 words)
|
|
| |
| | Truvada |
 | | To learn more about how this once-a-day HIV treatment is used, click here. |  | | Truvada is an anti-HIV drug in the nucleoside reverse transcriptase inhibitor (NRTI or "nuke") family and is always given in combination with other anti-HIV drugs. |
|
http://www.truvada.com
(391 words)
|
|
| |
| | APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active ... |
 | | therapy uses two classes of drugs: reverse transcriptase (RT) |  | | A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. |  | | Tavel, J. A., Miller, K. and Masur, H. Guide to major clinical trials of antiretroviral therapy in human immunodeficiency virus-infected patients: protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors. |
|
http://jac.oupjournals.org/cgi/content/full/51/5/1181
(4627 words)
|
|
| |
| | Detection of Mycobacterium tuberculosis Group Organisms in Human and Mouse Joint Tissue by Reverse Transcriptase PCR: ... |
 | | Previous studies from our laboratory using reverse transcriptase |  | | Synovial tissue RNAs of patients from cohorts 1 and 2 were reverse transcribed and subjected to analysis for bacteria and |  | | Detection of Mycobacterium tuberculosis Group Organisms in Human and Mouse Joint Tissue by Reverse Transcriptase PCR: Prevalence in Diseased Synovial Tissue Suggests Lack of Specific Association with Rheumatoid Arthritis -- Kempsell et al. |
|
http://iai.asm.org/cgi/content/full/69/3/1821
(5692 words)
|
|
| |
| | Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse ... |
 | | Table 1 Characteristics of 14 randomised controlled trials comparing protease inhibitor based triple therapy and non-nucleoside analogue reverse transcriptase inhibitor (NNRTI) based triple regimens with dual therapy |  | | Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens. |  | | A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. |
|
http://bmj.com/cgi/content/full/328/7434/249
(4060 words)
|
|
| |
| | Reverse transcriptase - Wikipedia, the free encyclopedia |
 | | Reverse transcriptase is commonly used in research to apply the polymerase chain reaction technique to RNA. |  | | The classical PCR technique can only be applied to DNA strands, but with the help of reverse transcriptase, RNA can be transcribed into DNA, thus making PCR analysis of RNA molecules possible. |  | | The technique is collectively called Reverse Transcription-Polymerase Chain Reaction (RT-PCR). |
|
http://www.wikipedia.org/wiki/Reverse_transcriptase
(516 words)
|
|
| |
| | Welcome to Emtriva.com - The online resource for Emtriva (emtricitabine) |
 | | Should you have any questions concerning the revised Prescribing Information, please contact the Gilead Medical Information Department at 1-800-GILEAD-5 (1-800-445-3235). |  | | (emtricitabine) — the second antiretroviral agent for the treatment of HIV-1 infection available from Gilead Sciences — is a one capsule, once-daily nucleoside reverse transcriptase inhibitor for use in combination with other antiretroviral drugs. |  | | This Web site is designed to help you learn more about Emtriva. |
|
http://www.emtriva.com
(331 words)
|
|
| |
| | Evidence for Copurification of HERV-K-Related Transcripts and a Reverse Transcriptase Activity in Human Platelets From ... |
 | | Evidence for Copurification of HERV-K-Related Transcripts and a Reverse Transcriptase Activity in Human Platelets From Patients With Essential Thrombocythemia |  | | Mwenda JM: Biochemical characterization of a reverse transcriptase activity associated with retroviral-like particles isolated from human placental villous tissue. |  | | Evidence for Copurification of HERV-K-Related Transcripts and a Reverse Transcriptase Activity in Human Platelets From Patients With Essential Thrombocythemia -- Boyd et al. |
|
http://www.bloodjournal.org/cgi/content/full/90/10/4022
(6530 words)
|
|
| |
| | 7th Conference - Abstract 81 |
 | | The effect of TPV on the pharmacokinetics of nucleoside reverse transcriptase inhibitors (NRTIs) was investigated in a Phase I/II study in HIV-1 infected patients. |  | | The Pharmacokinetics of Nucleoside Reverse Transcriptase Inhibitors when Coadministered with the HIV Protease Inhibitor Tipranavir in HIV-1 Infected Patients |  | | Methods: Patients on stable dual NRTIs for >2 months were randomized to one of 3 TPV dose groups: 900, 1200, or 1500 mg three times daily, administered as 150-mg hard-filled capsules. |
|
http://www.retroconference.org/2000/abstracts/81.htm
(341 words)
|
|
| |
| | Abstract 13 - TMC120, a New Non- Nucleoside Reverse Transcriptase Inhibitor, Is a Potent Antiretroviral in Treatment ... |
 | | Abstract 13 - TMC120, a New Non- Nucleoside Reverse Transcriptase Inhibitor, Is a Potent Antiretroviral in Treatment Naive, HIV-1 Infected Subjects. |  | | 13 TMC120, a New Non- Nucleoside Reverse Transcriptase Inhibitor, Is a Potent Antiretroviral in Treatment Naive, HIV-1 Infected Subjects. |  | | Background:TMC120 (R147681), a dianilinopyrimidine (DAPY) derivative, is a novel, non-nucleoside reverse transcriptase inhibitor (NNRTI) with equipotent in vitro activity (IC = 1-10 nM) against wild-type HIV-1 and NNRTI-resistant variants encoding K103N, Y181C or G190A/S mutations. |
|
http://www.retroconference.org/2001/abstracts/abstracts/abstracts/13.htm
(243 words)
|
|
| |
| | John Wrobel |
 | | Crystal Structure of the 66 kD subunit of the HIV-1 Reverse Transcriptase |  | | Besides providing a better understanding of the HIV-1 reverse transcriptase in particular, this project demonstrated the utility of saturation mutagenesis to study the function and stability of proteins in general, especially for proteins for which no structural data are available. |  | | Evalutated amino-acid substitutions in the reverse transcriptase of clinical HIV-1 isolates using phenotype data from a collection of HIV-1 reverse transcriptase mutants. |
|
http://www.unc.edu/%7Ewrobel
(1151 words)
|
|
| |
| | HIV RT 3D Structures Index |
 | | The HIV Drug Resistance Database at LANL and the HIV Drug Resistance Database at Stanford are both sources of information on sites in the protease and reverse transcriptase proteins which mutate to create drug resistance in the virus. |  | | Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. |  | | The Reverse Transcriptase Structures Table at the Protein Structures Database (PDB) contains RT structures and RT-related stuctures (such as E. coli Klenow fragment), collected as a part of the September 2002 "Molecule of the Month" project at PDB. |
|
http://hiv-web.lanl.gov/content/hiv-db/STRUCTURE/RT.HTML
(979 words)
|
|
| |
| | Notice to Readers: Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of ... |
 | | A previously published report provided guidelines for managing the pharmacologic interactions that can result when patients receive protease inhibitors and nonnucleoside reverse transcriptase inhibitors (NNRTIs) for treatment of human immunodeficiency virus (HIV) infection together with rifamycins for the treatment of tuberculosis (TB) (1). |  | | Concurrent use of NRTIs and rifamycins is not contraindicated and does not require dose adjustments. |  | | The other class of antiretroviral agents available in the United States---nucleoside reverse transcriptase inhibitors (NRTIs) (zidovudine, didanosine, zalcitabine, stavudine, lamivudine, and the new drug abacavir [2])---are not metabolized by CYP450. |
|
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4909a4.htm
(1090 words)
|
|
| |
| | An Accurate Look into HIV |
 | | The primary source of scientific results on reverse transcriptase (RT), the CABM is conducting X-ray crystallography studies on the enzyme. |  | | For extensive knowledge about HIV and its molecular biology, Larsen is relying upon Edward Arnold and his group at the Center for Advanced Biotechnology and Medicine (CABM) at Rutgers University. |  | | Teachers might show a less technical version in biology and biochemistry classes, while scientists might introduce their talks with the video and a more technical script. |
|
http://www.sdsc.edu/GatherScatter/GSsummer96/larsen.html
(1061 words)
|
|
| |
| | Downstream E-Box-mediated Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene Transcription: Evidence ... |
 | | Gu, J., Kagawa, S., Takakura, M., Kyo, S., Inoue, M., Roth, J.A., and Fang, B.L. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers. |  | | Devereux, T.R., Horikawa, I., Anna, C.H., Annab, L.A., Afshari, C.A., and Barrett, J.C. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. |  | | Majumdar, A.S., Hughes, D.E., Lichtsteiner, S.P., Wang, Z., Lebkowski, J.S., and Vasserot, A.P. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters. |
|
http://www.molbiolcell.org/cgi/content/full/13/8/2585
(7708 words)
|
|
| |
| | DNA Replication Enzymes |
 | | Reverse Transcriptase from HIV-1 is of tremendous medical interest as it is the target enzyme for the best known of anti-AIDS drugs, AZT, which acts by causing chain termination of the polymerase reaction. |  | | Knowledge of its detailed three dimensional structure will greatly assist the development of knew anti-AIDS drugs. |  | | The polymerase function of RT is then able to synthesise the second strand of DNA, possibly primed by a rump of the viral RNA. |
|
http://www.biochem.ucl.ac.uk/bsm/xtal/teach/repl/rt.html
(357 words)
|
|
| |
| | Nucleoside Reverse Transcriptase Inhibitors |
 | | The matrix below highlights key and common point mutations associated with the development of antiretroviral drug resistance and cross-resistance to Nucleoside Reverse Transcriptase Inhibitors (NRTI). |  | | Click on drug names, colored cells and mutations for additional and specific data. |
|
http://www.hivresistanceweb.com/protected/mutationtables/nrti.shtml
(53 words)
|
|
| |
| | Kivexa® - new one-a-day combination tablet for treatment of HIV launched |
 | | Treatment with Kivexa will, in one single daily pill, provide the double NRTI backbone component of triple therapy. |  | | Kivexa (abacavir/lamivudine), the first once-a-day, fixed-dose combination of two nucleoside reverse transcriptase inhibitors (NRTIs) with potent and durable virological control and a low risk of cross resistance, launches in the UK. |
|
http://www.medicalnewstoday.com/medicalnews.php?newsid=18732&nfid=mnf
(789 words)
|
|
| |
| | Arch Dermatol -- Abstract: A Meta-analysis of Reverse Transcriptase-Polymerase Chain Reaction for Tyrosinase mRNA as a ... |
 | | Uma Nadiminti, BA Arthur J. Sober, MD Michael Bigby, MD Arch Dermatol. |  | | Detection of Melanoma Cells in the Lymphatic Drainage after Lymph Node Dissection in Melanoma Patients by Using Two-Marker Reverse Transcriptase-Polymerase Chain Reaction Assay |  | | Arch Dermatol -- Abstract: A Meta-analysis of Reverse Transcriptase-Polymerase Chain Reaction for Tyrosinase mRNA as a Marker for Circulating Tumor Cells in Cutaneous Melanoma, March 2001, Tsao et al. |
|
http://archderm.ama-assn.org/cgi/content/abstract/137/3/325
(373 words)
|
|
| |
| | GLOSSARY R |
 | | (the reverse of transcription); used by retroviruses as well as in biotechnology. |
|
http://www.emc.maricopa.edu/faculty/farabee/BIOBK/BioBookglossR.html
(1159 words)
|
|
|